{"DataElement":{"publicId":"3119292","version":"1","preferredName":"Malignant Neoplasm Mitotic Count Rate Square Millimeter Value","preferredDefinition":"Numeric value for the number of mitoses within a square millimeter of a tumor specimen.","longName":"3119280v1.0:3119289v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3119280","version":"1","preferredName":"Malignant Neoplasm Mitotic Count Rate","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004_The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields._A measurement of degree, speed, or frequency relative to time. (NCI)","longName":"2186369v1.0:3119278v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3119278","version":"1","preferredName":"Mitotic Count Rate","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.:A measurement of degree, speed, or frequency relative to time. (NCI)","longName":"C47864:C25636","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Count","conceptCode":"C47864","definition":"The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Rate","conceptCode":"C25636","definition":"A measurement of degree, speed, or frequency relative to time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-85C7-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-85D8-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3119289","version":"1","preferredName":"Mitotic Count Rate Square Millimeter Value","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields._A measurement of degree, speed, or frequency relative to time. (NCI)_A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter._A numerical quantity measured or assigned or computed.","longName":"3119289v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"Numeric Alpha DVG","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AD29185-8631-9FE8-E040-BB89AD434B5D","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3119288","version":"1","preferredName":"Mitotic Count Rate Square Millimeter Value","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.:A measurement of degree, speed, or frequency relative to time. (NCI):A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.:A numerical quantity measured or assigned or computed.","longName":"C47864:C25636:C65104:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Count","conceptCode":"C47864","definition":"The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Rate","conceptCode":"C25636","definition":"A measurement of degree, speed, or frequency relative to time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Square Millimeter","conceptCode":"C65104","definition":"A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-860A-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-861B-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"}]}],"AlternateNames":[{"name":"malignant_neoplasm_mitotic_count_rate","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Mitotic rate","type":"Preferred Question Text","description":"Mitotic rate","url":null,"context":"NCIP"},{"name":"TCGA Question Text","type":"Alternate Question Text","description":"Highest Mitotic Rate among known primaries included at initial diagnosis","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AD29185-863B-9FE8-E040-BB89AD434B5D","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-07","modifiedBy":"TSESU","dateModified":"2018-07-10","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 7/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}